UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1090) 1090
double-blind method (1055) 1055
science & technology (989) 989
life sciences & biomedicine (985) 985
male (925) 925
female (921) 921
middle aged (788) 788
aged (729) 729
treatment outcome (468) 468
abridged index medicus (418) 418
cardiovascular system & cardiology (411) 411
adult (365) 365
cardiac & cardiovascular systems (305) 305
drug therapy (268) 268
clinical trials (252) 252
heart attacks (231) 231
risk factors (210) 210
prospective studies (204) 204
aspirin (194) 194
general & internal medicine (193) 193
time factors (193) 193
aged, 80 and over (184) 184
medicine, general & internal (182) 182
care and treatment (180) 180
follow-up studies (180) 180
platelet aggregation inhibitors - therapeutic use (175) 175
drug therapy, combination (169) 169
stroke (161) 161
cardiovascular disease (152) 152
dose-response relationship, drug (148) 148
peripheral vascular disease (145) 145
patients (141) 141
platelet aggregation inhibitors - administration & dosage (136) 136
mortality (135) 135
platelet aggregation inhibitors - adverse effects (129) 129
aspirin - therapeutic use (127) 127
hemorrhage - chemically induced (126) 126
ticlopidine - analogs & derivatives (124) 124
aspirin - administration & dosage (123) 123
analysis (113) 113
research (113) 113
cardiovascular (107) 107
anticoagulants (106) 106
drug administration schedule (106) 106
aspirin - adverse effects (105) 105
prevention (105) 105
dosage and administration (102) 102
myocardial infarction (101) 101
cardiology (100) 100
pharmacology & pharmacy (98) 98
surgery (96) 96
acute coronary syndromes (94) 94
cardiovascular diseases (94) 94
drug dosages (94) 94
ischemia (93) 93
coronary vessels (92) 92
administration, oral (90) 90
health aspects (90) 90
studies (89) 89
adolescent (87) 87
neurosciences & neurology (87) 87
diabetes (86) 86
kaplan-meier estimate (85) 85
thrombosis (85) 85
incidence (82) 82
medical research (81) 81
medicine & public health (81) 81
clinical neurology (79) 79
young adult (78) 78
cardiac patients (77) 77
blood platelets (76) 76
heart failure (75) 75
bleeding (74) 74
stroke - prevention & control (74) 74
blood pressure (73) 73
clopidogrel (73) 73
coronary heart disease (73) 73
ticlopidine - therapeutic use (71) 71
anticoagulants - therapeutic use (70) 70
cross-over studies (69) 69
ticlopidine - administration & dosage (68) 68
internal medicine (67) 67
risk assessment (67) 67
usage (67) 67
cardiovascular diseases - prevention & control (66) 66
stents (66) 66
hemorrhage (65) 65
myocardial infarction - prevention & control (65) 65
thromboembolism (65) 65
biomarkers - blood (63) 63
hypertension (62) 62
myocardial infarction - drug therapy (62) 62
proportional hazards models (62) 62
hematology (61) 61
research design (61) 61
angina pectoris (60) 60
electrocardiography (60) 60
secondary prevention (60) 60
medicine, experimental (58) 58
placebos (55) 55
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JAMA : the journal of the American Medical Association, ISSN 0098-7484, 03/2015, Volume 313, Issue 11, pp. 1113 - 1121
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 03/2015, Volume 65, Issue 8, pp. 777 - 786
Background The currently recommended duration of dual antiplatelet therapy (DAPT) in drug-eluting stent... 
double antiplatelet duration | percutaneous coronary angioplasty | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Postoperative Complications - prevention & control | Male | Hemorrhage - prevention & control | Aspirin - administration & dosage | Drug-Eluting Stents - adverse effects | Middle East | Early Termination of Clinical Trials | Coronary Restenosis - diagnosis | Coronary Artery Disease - physiopathology | Time Factors | Aspirin - adverse effects | Percutaneous Coronary Intervention - methods | Hemorrhage - etiology | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - adverse effects | Ticlopidine - administration & dosage | Female | Everolimus | Coronary Restenosis - etiology | Platelet Aggregation Inhibitors - adverse effects | Coronary Vessels - pathology | Sirolimus - analogs & derivatives | Sirolimus - therapeutic use | Europe | Coronary Restenosis - prevention & control | Treatment Outcome | Coronary Artery Disease - mortality | Postoperative Complications - diagnosis | Ticlopidine - analogs & derivatives | Coronary Artery Disease - therapy | Coronary Artery Disease - diagnosis | Coronary Vessels - surgery | Aged | Percutaneous Coronary Intervention - adverse effects | Aspirin | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
JACC. Cardiovascular interventions, ISSN 1936-8798, 05/2017, Volume 10, Issue 9, pp. 942 - 954
...) experience different reductions in ischemic event and increases in bleeding events with extended duration dual antiplatelet therapy versus those without PAD... 
dual antiplatelet therapy | peripheral arterial disease | bleeding | ischemia | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Percutaneous Coronary Intervention - mortality | Humans | Middle Aged | Male | Peripheral Arterial Disease - complications | Aspirin - administration & dosage | Percutaneous Coronary Intervention - instrumentation | Time Factors | Aspirin - adverse effects | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - adverse effects | Ticlopidine - administration & dosage | Female | Prasugrel Hydrochloride - administration & dosage | Drug Therapy, Combination | Myocardial Infarction - etiology | Stents | Platelet Aggregation Inhibitors - adverse effects | Double-Blind Method | Drug Administration Schedule | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Prasugrel Hydrochloride - adverse effects | Coronary Artery Disease - mortality | Ticlopidine - analogs & derivatives | Peripheral Arterial Disease - mortality | Coronary Artery Disease - diagnostic imaging | Stroke - etiology | Coronary Artery Disease - therapy | Peripheral Arterial Disease - diagnosis | Coronary Artery Disease - complications | Clopidogrel | Aged | Coronary Thrombosis - etiology | Hemorrhage - chemically induced | Percutaneous Coronary Intervention - adverse effects | Index Medicus
Journal Article
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 10/2017, Volume 70, Issue 18, pp. 2213 - 2223
Subjects undergoing coronary stenting with complex lesion anatomy may experience different risks and benefits with prolonged dual antiplatelet therapy... 
complex lesions | dual antiplatelet therapy | percutaneous coronary intervention | dual antiplatelet therapy score | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Myocardial Infarction - chemically induced | Coronary Artery Disease - surgery | Follow-Up Studies | Humans | Middle Aged | Male | Aspirin - administration & dosage | Pyridines - adverse effects | Aspirin - adverse effects | Hemorrhage - etiology | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - adverse effects | Ticlopidine - administration & dosage | Female | Myocardial Infarction - etiology | Platelet Aggregation Inhibitors - adverse effects | Percutaneous Coronary Intervention - trends | Drug-Eluting Stents | Pyridines - administration & dosage | Double-Blind Method | Drug Administration Schedule | Treatment Outcome | Coronary Artery Disease - drug therapy | Ticlopidine - analogs & derivatives | Coronary Artery Disease - diagnostic imaging | Internationality | Clopidogrel | Aged | Hemorrhage - chemically induced | Percutaneous Coronary Intervention - adverse effects | Transluminal angioplasty | Myocardial infarction | Intervention | Therapy | Surgical implants | Heart attacks | Angioplasty | Bifurcations | Cardiovascular disease | Bleeding | Complexity | Confidence intervals | Cost-benefit analysis | Consortia | Randomization | Ischemia | Implants | Lesions | Thromboembolism | Stents | Aspirin | FDA approval | Anatomy | Thrombosis | Studies | Coronary vessels | Infarction | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 1533-4406, 08/2011, Volume 365, Issue 8, pp. 699 - 708
Journal Article
JACC. Cardiovascular interventions, ISSN 1936-8798, 2015, Volume 8, Issue 12, pp. 1552 - 1562
Journal Article
Journal Article
Journal Article